Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Nilsson

Showing results (141-150 of 187) with videos related to

Pageof 19
Sort By:
Antimicrobial Agents and Chemotherapy|May 18, 2011
Antiviral activity and mode of action of TMC647078, a novel nucleoside inhibitor of the hepatitis C virus NS5B polymeraseJan Martin Berke, Leen Vijgen, Sophie Lachau-Durand, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2010
Synthesis and SAR of potent inhibitors of the Hepatitis C virus NS3/4A protease: exploration of P2 quinazoline substituentsMagnus Nilsson, Anna Karin Belfrage, Stefan Lindström, et al.
Annals of Surgery|September 1, 2017
Learning Curve and Associated Morbidity of Minimally Invasive Esophagectomy: A Retrospective Multicenter StudyFrans van Workum, Marianne H B C Stenstra, Gijs H K Berkelmans, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 14, 2026
Health-related quality of life comparing standard and prolonged time-to-surgery after neoadjuvant chemoradiotherapy for esophageal cancer: results from the multicenter, randomized, controlled NeoRes II trialAnders Holmén, Fahad Murad, Klara Nilsson, et al.
Journal of Medicinal Chemistry|November 2, 2010
2'-Deoxy-2'-spirocyclopropylcytidine revisited: a new and selective inhibitor of the hepatitis C virus NS5B polymeraseTim H M Jonckers, Tse-I Lin, Christophe Buyck, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|April 26, 2024
Western European Variation in the Organization of Esophageal Cancer Surgical CareMaurits R Visser, Daan M Voeten, Suzanne S Gisbertz, et al.
Drug Design, Development and Therapy|September 7, 2022
Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of AsthmaMagnus Nilsson, Magdalena Rhedin, Ramon Hendrickx, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2008
Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350Pierre Raboisson, Herman de Kock, Asa Rosenquist, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2022
Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancerTiuri E Kroese, Peter S N van Rossum, Magnus Nilsson, et al.
Annals of Surgery|October 22, 2019
Anastomotic Techniques and Associated Morbidity in Total Minimally Invasive Transthoracic Esophagectomy: Results From the EsoBenchmark DatabaseWolfgang Schröder, Dimitri A Raptis, Henner M Schmidt, et al.
Pageof 19

Showing results (141-150 of 187) with videos related to

Sort By:
Pageof 19
Antimicrobial Agents and Chemotherapy|May 18, 2011
Antiviral activity and mode of action of TMC647078, a novel nucleoside inhibitor of the hepatitis C virus NS5B polymeraseJan Martin Berke, Leen Vijgen, Sophie Lachau-Durand, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2010
Synthesis and SAR of potent inhibitors of the Hepatitis C virus NS3/4A protease: exploration of P2 quinazoline substituentsMagnus Nilsson, Anna Karin Belfrage, Stefan Lindström, et al.
Annals of Surgery|September 1, 2017
Learning Curve and Associated Morbidity of Minimally Invasive Esophagectomy: A Retrospective Multicenter StudyFrans van Workum, Marianne H B C Stenstra, Gijs H K Berkelmans, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 14, 2026
Health-related quality of life comparing standard and prolonged time-to-surgery after neoadjuvant chemoradiotherapy for esophageal cancer: results from the multicenter, randomized, controlled NeoRes II trialAnders Holmén, Fahad Murad, Klara Nilsson, et al.
Journal of Medicinal Chemistry|November 2, 2010
2'-Deoxy-2'-spirocyclopropylcytidine revisited: a new and selective inhibitor of the hepatitis C virus NS5B polymeraseTim H M Jonckers, Tse-I Lin, Christophe Buyck, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|April 26, 2024
Western European Variation in the Organization of Esophageal Cancer Surgical CareMaurits R Visser, Daan M Voeten, Suzanne S Gisbertz, et al.
Drug Design, Development and Therapy|September 7, 2022
Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of AsthmaMagnus Nilsson, Magdalena Rhedin, Ramon Hendrickx, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2008
Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350Pierre Raboisson, Herman de Kock, Asa Rosenquist, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2022
Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancerTiuri E Kroese, Peter S N van Rossum, Magnus Nilsson, et al.
Annals of Surgery|October 22, 2019
Anastomotic Techniques and Associated Morbidity in Total Minimally Invasive Transthoracic Esophagectomy: Results From the EsoBenchmark DatabaseWolfgang Schröder, Dimitri A Raptis, Henner M Schmidt, et al.
Pageof 19